Due to ongoing uncertainties surrounding the current pandemic regulations, the faculty of CVNUK decided to replace this year’s physical conference with an online conference which took place on 27th November 2020. This features a variety of presentations focused on the development of a vaccine for Covid-19.
The recordings of the virtual conference are now available.
If you were unable to attend but would still like to view the sessions, please register via the button below and you will receive an email with a link to view the recorded sessions.
If you have any queries please email email@example.com.
See below for the updated timetable.
I am Chief Investigator and clinical lead on the blood-stage and transmission blocking malaria vaccine programmes headed by Prof Simon Draper and Prof Sumi Biswas. This programme of work includes testing of first-time-in-man vaccines against both Plasmodium falciparum and P. vivax malaria, incorporating controlled human malaria infection to test efficacy. I am currently running a first-time-in-man Phase I/IIa trial of the protein vaccine RH5.1/AS01B, which incorporates the PfRH5 antigen – the first reported target in the P. falciparum merozoite that is highly susceptible to broadly-neutralising vaccine-induced antibodies.
My main research interest is in human challenge models of infection, having completed a DPhil at the Jenner Institute in 2009 which involved development of a human challenge model against tuberculosis, using BCG as a surrogate. Prior to this I was lead investigator on several TB vaccine trials, including that of the first candidate prophylactic TB vaccine to have been administered to HIV-infected individuals.
I am a qualified Consultant in Infectious Diseases and Microbiology, having completed my specialist training at OUH NHS Trust in 2014, and spent a year working as a Consultant in Infectious Diseases at the Heart of England NHS Trust in Birmingham. I continue working there as an Honorary Consultant.